Fingerprint
Dive into the research topics of 'Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the "best" therapy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the "best" therapy?
Meetu Agrawal, Ravin J. Garg, Hagop Kantarjian, Jorge Cortes
Research output: Contribution to journal › Review article › peer-review
27
Scopus
citations